EODData

MEMBERSHIP REGISTER LOG IN

FRA, G49N: GenSight Biologics S.A

07 Nov 2025
LAST:

0.1282

CHANGE:
 0.00		OPEN:
0.1282		HIGH:
0.1282		ASK:
0.0000		VOLUME:
10.0K
CHG(%):
2.23		PREV:
0.1254		LOW:
0.1282		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 250.12820.12820.12820.128210.0K
06 Nov 250.12540.12540.12540.125410.0K
05 Nov 250.12640.12640.12640.126410.0K
04 Nov 250.12000.12000.12000.120010.0K
31 Oct 250.14820.14820.14820.148210.0K
30 Oct 250.11140.22500.11140.225010.0K
29 Oct 250.11580.11580.11580.115810.0K
28 Oct 250.11700.11700.11700.117010.0K
27 Oct 250.12000.12000.12000.120010.0K
24 Oct 250.11260.11260.11260.112610.0K

COMPANY PROFILE

Name:GenSight Biologics S.A
About:GenSight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ, a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa and dry age-related macular degeneration. The company is also developing products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. It has license agreements with Sorbonne Université, CNRS, Inserm and SATT Lutech; Inserm Transfert S.A, Genethon, and Harvard; Massachusetts Institute of Technology; Novartis Pharma AG; Sorbonne University, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale and Satt Lutech; Association Française contre les Myopathies, Inserm Transfert S.A; and non-exclusive license agreement with Adverum Biotechnologies. The company was incorporated in 2012 and is headquartered in Paris, France.
Sector:Healthcare
Industry:Biotechnology
Address:74, rue du Faubourg Saint-Antoine, Paris, France, 75012
Website:https://www.gensight-biologics.com
ISIN:FR0013183985

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.131.1%
MA10:0.134.4%
MA20:0.132.3%
MA50:0.1411.5%
MA100:0.1515.9%
MA200:0.1840.9%
STO9:11.36 
STO14:13.88 
RSI14:49.04
WPR14:-86.12 
MTM14:0.01
ROC14:0.04 
ATR:0.02 
Week High:0.1515.6%
Week Low:0.126.8%
Month High:0.2375.5%
Month Low:0.1140.9%
Year High:0.33158.2%
Year Low:0.1115.5%
Volatility:35.31